Antimitogenic effects of HDL and APOE mediated by Cox-2-dependent IP activation.
D000818:Animals; D001011:Aorta / Q000033:anatomy & histology; D001057:Apolipoproteins E / Q000378:metabolism*; D002478:Cells, Cultured; D019925:Cyclin A / Q000235:genetics / Q000378:metabolism; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000378:metabolism; D005786:Gene Expression Regulation; D006801:Humans; D007527:Isoenzymes / Q000378:metabolism*; D008075:Lipoproteins, HDL / Q000378:metabolism*; D008565:Membrane Proteins; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009130:Muscle, Smooth / Q000166:cytology / Q000378:metabolism; D032389:Myocytes, Smooth Muscle / Q000166:cytology / Q000378:metabolism*; D011401:Promoter Regions, Genetic; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism*; D051381:Rats; D044006:Receptors, Epoprostenol; D011982:Receptors, Prostaglandin / Q000235:genetics / Q000378:metabolism*; D016196:S Phase / Q000502:physiology*; D013449:Sulfonamides / Q000378:metabolism
D001057:Apolipoproteins E; D019925:Cyclin A; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D007527:Isoenzymes; D008075:Lipoproteins, HDL; D008565:Membrane Proteins; C113936:PTGIR protein, human; C491910:Ptgir protein, mouse; C491909:Ptgir protein, rat; D044006:Receptors, Epoprostenol; D011982:Receptors, Prostaglandin; D013449:Sulfonamides; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases; C012655:nimesulide